ANI Pharmaceuticals Inc (ANIP)

ANI Pharmaceuticals (ANIP) Stock Price & Analysis


ANIP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$31.21 - $65.89
Previous Close$58.06
Average Volume (3M)157.57K
Market Cap
Enterprise Value$1.30B
Total Cash (Recent Filing)$161.71M
Total Debt (Recent Filing)$286.09M
Price to Earnings (P/E)-129.7
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding20,287,425
10 Day Avg. Volume113,013
30 Day Avg. Volume157,567
Standard Deviation0.13
Financial Highlights & Ratios
Price to Book (P/B)7.80
Price to Sales (P/S)10.11
Price to Cash Flow (P/CF)14.30
P/FCF Ratio14.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.24
Enterprise Value/Gross Profit7.33
Enterprise Value/Ebitda20.98
Price Target Upside26.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was ANI Pharmaceuticals Inc’s price range in the past 12 months?
ANI Pharmaceuticals Inc lowest stock price was $31.21 and its highest was $65.89 in the past 12 months.
    What is ANI Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is ANI Pharmaceuticals Inc’s upcoming earnings report date?
    ANI Pharmaceuticals Inc’s upcoming earnings report date is Nov 08, 2023 which is in 37 days.
      How were ANI Pharmaceuticals Inc’s earnings last quarter?
      ANI Pharmaceuticals Inc released its earnings results on Aug 09, 2023. The company reported $1.28 earnings per share for the quarter, beating the consensus estimate of $0.667 by $0.613.
        Is ANI Pharmaceuticals Inc overvalued?
        According to Wall Street analysts ANI Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does ANI Pharmaceuticals Inc pay dividends?
          ANI Pharmaceuticals Inc does not currently pay dividends.
          What is ANI Pharmaceuticals Inc’s EPS estimate?
          ANI Pharmaceuticals Inc’s EPS estimate is $0.77.
            How many shares outstanding does ANI Pharmaceuticals Inc have?
            ANI Pharmaceuticals Inc has 20,280,798 shares outstanding.
              What happened to ANI Pharmaceuticals Inc’s price movement after its last earnings report?
              ANI Pharmaceuticals Inc reported an EPS of $1.28 in its last earnings report, beating expectations of $0.667. Following the earnings report the stock price went up 9.208%.
                Which hedge fund is a major shareholder of ANI Pharmaceuticals Inc?
                Among the largest hedge funds holding ANI Pharmaceuticals Inc’s share is Defender Capital, LLC.. It holds ANI Pharmaceuticals Inc’s shares valued at 1M.


                  ANI Pharmaceuticals Stock Smart Score

                  The ANI Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  ANI Pharmaceuticals Inc

                  ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.


                  Top 5 ETFs holding ANIP

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard U.S. Momentum Factor ETF
                  Vanguard Russell 3000 ETF
                  Invesco S&P US Total Market ESG Tilt Index ETF Trust Units -CAD Hedged-
                  Invesco S&P US Total Market ESG Tilt Index ETF Trust Units
                  Up to five ETFs with an Outperform Smart Score that hold ANIP. The ETFs are listed according to market value of ANIP within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Supernus Pharmaceuticals
                  ACADIA Pharmaceuticals
                  PTC Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis